Shire plc, a leading global biotechnology company headquartered in Ireland (IE), focuses on developing innovative therapies for rare diseases and complex conditions. Founded in 1986, Shire has established a strong presence in key operational regions, including North America, Europe, and Asia. Specialising in areas such as neuroscience, immunology, and genetic disorders, Shire is renowned for its unique portfolio of products, including treatments for attention deficit hyperactivity disorder (ADHD) and rare genetic conditions. The company has achieved significant milestones, including numerous FDA approvals and a robust pipeline of therapies that address unmet medical needs. With a commitment to improving patient outcomes, Shire plc has solidified its position as a market leader in the biotechnology sector, recognised for its dedication to innovation and excellence in healthcare.
We don't have data for Shire plc, but we can show you information about their parent organization instead.
View parent company